LUTZ, Fla.--(BUSINESS WIRE)--CytoDyn Inc. (the "Company") (OTC QB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency virus and other antibody applications, announced today that Kenneth J. Van Ness, the Company's President and Chief Executive Officer, will be presenting at The Wall Street Forum's 23rd Annual Analyst Conference on Tuesday, April 10, 2012 at 9:50 am EST.
